Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP412607.RA4AKIaHGJCvoAkeFdzhXvOFxEgZGKkIElDEHoEUy_JzY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP412607.RA4AKIaHGJCvoAkeFdzhXvOFxEgZGKkIElDEHoEUy_JzY130_assertion type Assertion NP412607.RA4AKIaHGJCvoAkeFdzhXvOFxEgZGKkIElDEHoEUy_JzY130_head.
- NP412607.RA4AKIaHGJCvoAkeFdzhXvOFxEgZGKkIElDEHoEUy_JzY130_assertion description "[To determine the clinical utility of FISH for del(5q) in MDS/AML, we first compared FISH for 5q31 (EGR1) and 5q33 (CSF1R) in 51 myeloid neoplasms containing del(5q) by metaphase cytogenetics.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP412607.RA4AKIaHGJCvoAkeFdzhXvOFxEgZGKkIElDEHoEUy_JzY130_provenance.
- NP412607.RA4AKIaHGJCvoAkeFdzhXvOFxEgZGKkIElDEHoEUy_JzY130_assertion evidence source_evidence_literature NP412607.RA4AKIaHGJCvoAkeFdzhXvOFxEgZGKkIElDEHoEUy_JzY130_provenance.
- NP412607.RA4AKIaHGJCvoAkeFdzhXvOFxEgZGKkIElDEHoEUy_JzY130_assertion SIO_000772 19608274 NP412607.RA4AKIaHGJCvoAkeFdzhXvOFxEgZGKkIElDEHoEUy_JzY130_provenance.
- NP412607.RA4AKIaHGJCvoAkeFdzhXvOFxEgZGKkIElDEHoEUy_JzY130_assertion wasDerivedFrom befree-20140225 NP412607.RA4AKIaHGJCvoAkeFdzhXvOFxEgZGKkIElDEHoEUy_JzY130_provenance.
- NP412607.RA4AKIaHGJCvoAkeFdzhXvOFxEgZGKkIElDEHoEUy_JzY130_assertion wasGeneratedBy ECO_0000203 NP412607.RA4AKIaHGJCvoAkeFdzhXvOFxEgZGKkIElDEHoEUy_JzY130_provenance.